Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Expression data from head and neck squamous cell carcinoma
GEO Series GSE6631. Homo sapiens. 44 samples. Type: Expression profiling by array.
Genome-wide enhancer analysis reveals the role of AP-1 transcription factor in head and neck squamous cell carcinoma [ChIP-Seq]
GEO Series GSE172321. Mus musculus. 18 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients
ClinicalTrials.gov study NCT02143622. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)
ClinicalTrials.gov study NCT06647563. IPD Sharing: NO. Countries: 0. Publications: 0.
Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)
ClinicalTrials.gov study NCT00268671. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05743777. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06199271. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
ClinicalTrials.gov study NCT03342352. IPD Sharing: NO. Countries: 0. Publications: 0.
Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)
ClinicalTrials.gov study NCT07147426. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04093115. IPD Sharing: NO. Countries: 0. Publications: 0.
Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05773079. IPD Sharing: Not stated. Countries: 0. Publications: 0.
BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
ClinicalTrials.gov study NCT05299203. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Intensity-modulated Radiotherapy in Patients With Squamous Cell Carcinoma of Unknown Primary (SCCUP) of the Head and Neck
ClinicalTrials.gov study NCT02112344. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT01427205. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06199947. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT04831450. IPD Sharing: NO. Countries: 0. Publications: 0.
Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT04129320. IPD Sharing: NO. Countries: 0. Publications: 0.
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02916368. IPD Sharing: YES. Countries: 0. Publications: 0.
Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT05845307. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06530914. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.